Bayer Gets FDA Nod for Novel Drug to Treat Hot Flashes

Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top